Lotus Eye Hospital And Institute logo

LOTUSEYE - Lotus Eye Hospital And Institute Share Price

₹34.6 -0.2  -0.6%

Last Trade - 26/02/21

Sector
Healthcare
Size
Micro Cap
Market Cap £7.13m
Enterprise Value £6.46m
Revenue £2.93m
Position in Universe 1871st / 3056
Bullish
Bearish
Unlock LOTUSEYE Revenue
Momentum
Relative Strength (%)
1m -8.47%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -14.4%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
299 311.3 339.6 380.2 384.3 405.5 +6.3%
+368.7 +283.6 -48.9 +78.8
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 31 December 2020, LotusEye Hospital and Institute Ltd revenues decreased 33% toRS218M. Net income applicable to common stockholdersdecreased 77% to RS4.6M. Revenues reflect a decrease indemand for the Company's products and services due tounfavorable market conditions. Net income also reflectsOther Income decrease of 25% to RS5.6M (income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

LOTUSEYE Revenue Unlock LOTUSEYE Revenue

Net Income

LOTUSEYE Net Income Unlock LOTUSEYE Revenue

Normalised EPS

LOTUSEYE Normalised EPS Unlock LOTUSEYE Revenue

PE Ratio Range

LOTUSEYE PE Ratio Range Unlock LOTUSEYE Revenue

Dividend Yield Range

LOTUSEYE Dividend Yield Range Unlock LOTUSEYE Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
LOTUSEYE EPS Forecasts Unlock LOTUSEYE Revenue
Profile Summary

Lotus Eye Hospital and Institute Limited, formerly Lotus Eye Care Hospital Limited, is an India-based company, which offers healthcare services. The Company operates primarily in the field of ophthalmology (Eye) and its related operation. The Company has approximately seven centers, located at Peelamedu, R.S. Puram, Mettupalayam, Tirupur, Salem, Cochin and Mulanthurthy. The Company offers a range of services for various eye conditions, such as cataracts and intraocular, retina and uvea, cornea, glaucoma, pediatric, orbit and oculoplasty, neuro ophthalmology and refractive. The Company also operates an eye bank, which is connected with its satellite centers located in Salem, Tirupur, Mettupalayam, R.S Puram and Cochin. The Company also generates revenues from pharmacy sales, and contact lens and optical.

Directors
Last Annual March 31st, 2020
Last Interim December 31st, 2020
Incorporated March 14, 1997
Public Since July 11, 2008
No. of Shareholders: n/a
No. of Employees: 209
Sector Healthcare
Industry Healthcare Providers & Services
Index
Exchange National Stock Exchange of India
Shares in Issue 20,796,330
Free Float (0.0%)
Eligible for
ISAs
SIPPs
LOTUSEYE Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for LOTUSEYE
Upcoming Events for LOTUSEYE
Frequently Asked Questions for Lotus Eye Hospital and Institute
What is the Lotus Eye Hospital and Institute share price?

As of 26/02/21, shares in Lotus Eye Hospital and Institute are trading at ₹34.6, giving the company a market capitalisation of £7.13m. This share price information is delayed by 15 minutes.

How has the Lotus Eye Hospital and Institute share price performed this year?

Shares in Lotus Eye Hospital and Institute are currently trading at ₹34.6 and the price has moved by 36.31% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Lotus Eye Hospital and Institute price has moved by 5.94% over the past year.

What are the analyst and broker recommendations for Lotus Eye Hospital and Institute?

There are no analysts currently covering Lotus Eye Hospital and Institute.

When will Lotus Eye Hospital and Institute next release its financial results?

Lotus Eye Hospital and Institute is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Lotus Eye Hospital and Institute dividend yield?

Lotus Eye Hospital and Institute does not currently pay a dividend.

Does Lotus Eye Hospital and Institute pay a dividend?

Lotus Eye Hospital and Institute does not currently pay a dividend.

When does Lotus Eye Hospital and Institute next pay dividends?

Lotus Eye Hospital and Institute does not currently pay a dividend.

How do I buy Lotus Eye Hospital and Institute shares?

To buy shares in Lotus Eye Hospital and Institute you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Lotus Eye Hospital and Institute?

Shares in Lotus Eye Hospital and Institute are currently trading at ₹34.6, giving the company a market capitalisation of £7.13m.

Where are Lotus Eye Hospital and Institute shares listed? Where are Lotus Eye Hospital and Institute shares listed?

Here are the trading details for Lotus Eye Hospital and Institute:

Country of listing: India
Exchange: NSI
Ticker Symbol: LOTUSEYE
What kind of share is Lotus Eye Hospital and Institute?

Based on an overall assessment of its quality, value and momentum, Lotus Eye Hospital and Institute is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Lotus Eye Hospital and Institute share price forecast 2021?

We were not able to load any forecast data for Lotus Eye Hospital and Institute.

How can I tell whether the Lotus Eye Hospital and Institute share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Lotus Eye Hospital and Institute. Over the past six months, the relative strength of its shares against the market has been -18.05%. At the current price of ₹34.6, shares in Lotus Eye Hospital and Institute are trading at 12.55% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Lotus Eye Hospital and Institute PE Ratio?

We were not able to find PE ratio data for Lotus Eye Hospital and Institute.

Who are the key directors of Lotus Eye Hospital and Institute?

Lotus Eye Hospital and Institute's management team is headed by:

Sangeetha Sundaramoorthy - MDR
Devarayapuram Kaarthikeyan - NID
Yogesh Shah - NID
R. Subramanian - NID
Kavetha Sundaramoorthy - CHM
M. Alagiriswamy - NID
Aakanksha Parmar - CCO
K.S. Ramalingam - CEO
A. Ganesh - CFO
S. Natesan - NID
Who are the major shareholders of Lotus Eye Hospital and Institute?

Here are the top five shareholders of Lotus Eye Hospital and Institute based on the size of their shareholding:

Sundaramoorthy (Kavetha) Individual Investor
Percentage owned: 54.19% (11.3m shares)
Kovai Purani Finance, Ltd. Corporation
Percentage owned: 5.52% (1.15m shares)
Vramath Investment Consultancy Pvt. Ltd. Corporation
Percentage owned: 4.81% (1,000k shares)
Choudhary (Sangeeta) Individual Investor
Percentage owned: 3.62% (753k shares)
Kaliannagounder (Sundaramoorthy S) Individual Investor
Percentage owned: 2.41% (502k shares)
Similar to LOTUSEYE
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.